SE8300495D0 - Improvements in or relating to nasal pharmaceutical compositions - Google Patents

Improvements in or relating to nasal pharmaceutical compositions

Info

Publication number
SE8300495D0
SE8300495D0 SE8300495A SE8300495A SE8300495D0 SE 8300495 D0 SE8300495 D0 SE 8300495D0 SE 8300495 A SE8300495 A SE 8300495A SE 8300495 A SE8300495 A SE 8300495A SE 8300495 D0 SE8300495 D0 SE 8300495D0
Authority
SE
Sweden
Prior art keywords
relating
pharmaceutical compositions
nasal pharmaceutical
ciliary function
nasal
Prior art date
Application number
SE8300495A
Other languages
English (en)
Other versions
SE8300495L (sv
SE454402B (sv
Inventor
J-R Kiechel
F Acezat-Mispelter
D Plas
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8300495D0 publication Critical patent/SE8300495D0/sv
Publication of SE8300495L publication Critical patent/SE8300495L/sv
Publication of SE454402B publication Critical patent/SE454402B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE8300495A 1982-02-01 1983-01-31 Nasalt administrerbar farmaceutisk komposition innehallande en ergotpeptidalkaloid samt ett xantin SE454402B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8202781 1982-02-01

Publications (3)

Publication Number Publication Date
SE8300495D0 true SE8300495D0 (sv) 1983-01-31
SE8300495L SE8300495L (sv) 1983-08-02
SE454402B SE454402B (sv) 1988-05-02

Family

ID=10528017

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8300495A SE454402B (sv) 1982-02-01 1983-01-31 Nasalt administrerbar farmaceutisk komposition innehallande en ergotpeptidalkaloid samt ett xantin

Country Status (27)

Country Link
JP (1) JPS58134017A (sv)
AT (1) AT385656B (sv)
AU (1) AU565613B2 (sv)
BE (1) BE895750A (sv)
CA (1) CA1197783A (sv)
CH (1) CH653555A5 (sv)
DE (1) DE3302949A1 (sv)
DK (1) DK164771C (sv)
ES (1) ES519450A0 (sv)
FI (1) FI81258C (sv)
FR (1) FR2539994B1 (sv)
GR (1) GR81320B (sv)
HK (1) HK59989A (sv)
HU (1) HU191512B (sv)
IE (1) IE54532B1 (sv)
IL (1) IL67822A (sv)
IT (1) IT1197558B (sv)
KE (1) KE3888A (sv)
LU (1) LU84613A1 (sv)
MY (1) MY8700766A (sv)
NL (1) NL192325C (sv)
NZ (1) NZ203117A (sv)
PH (1) PH22198A (sv)
PT (1) PT76166B (sv)
SE (1) SE454402B (sv)
SG (1) SG34389G (sv)
ZA (1) ZA83673B (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0715285D0 (en) * 2007-08-06 2007-09-12 Britannia Pharmaceuticals Ltd Improvements in or relating to powdered medicaments for nasal delivery
GB0910375D0 (en) * 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
CA3088942C (en) * 2018-01-05 2023-01-03 Impel Neuropharma, Inc. Intranasal delivery of dihydroergotamine by precision olfactory device

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091569A (en) * 1960-08-26 1963-05-28 Mead Johnson & Co Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
GB1202885A (en) * 1966-12-22 1970-08-19 Sandoz Ltd Pharmaceutical compositions comprising alkaloids
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
FR2387035A1 (fr) * 1977-04-12 1978-11-10 Cassenne Lab Sa Nouveau medicament destine notamment au traitement des troubles fonctionnels cerebraux
DE2831728C2 (de) * 1978-07-19 1982-12-23 Krewel-Werke Gmbh, 5208 Eitorf Arzneimittel zur Behandlung von Kopfschmerzen

Also Published As

Publication number Publication date
NL192325B (nl) 1997-02-03
FI81258C (sv) 1990-10-10
NZ203117A (en) 1986-12-05
CH653555A5 (de) 1986-01-15
FI81258B (fi) 1990-06-29
JPS58134017A (ja) 1983-08-10
IT8347646A0 (it) 1983-02-01
SE8300495L (sv) 1983-08-02
IT1197558B (it) 1988-12-06
DK164771C (da) 1992-12-28
ES8502865A1 (es) 1985-02-01
ZA83673B (en) 1984-09-26
MY8700766A (en) 1987-12-31
KE3888A (en) 1989-09-01
IL67822A0 (en) 1983-06-15
HU191512B (en) 1987-02-27
ES519450A0 (es) 1985-02-01
PT76166B (en) 1986-02-04
LU84613A1 (fr) 1983-09-08
DK38183A (da) 1983-08-02
DE3302949A1 (de) 1983-08-11
NL192325C (nl) 1997-06-04
NL8300325A (nl) 1983-09-01
FR2539994A1 (fr) 1984-08-03
FR2539994B1 (fr) 1986-10-10
JPH0253406B2 (sv) 1990-11-16
FI830245A0 (fi) 1983-01-25
DE3302949C2 (sv) 1992-05-21
GR81320B (sv) 1984-12-11
IE830187L (en) 1983-08-01
ATA30383A (de) 1987-10-15
PH22198A (en) 1988-06-28
IL67822A (en) 1988-02-29
DK164771B (da) 1992-08-17
AU1085083A (en) 1983-08-11
SE454402B (sv) 1988-05-02
IE54532B1 (en) 1989-11-08
FI830245L (fi) 1983-08-02
DK38183D0 (da) 1983-01-31
AT385656B (de) 1988-05-10
PT76166A (en) 1983-02-01
HK59989A (en) 1989-08-04
AU565613B2 (en) 1987-09-24
CA1197783A (en) 1985-12-10
SG34389G (en) 1989-09-22
BE895750A (fr) 1983-08-01

Similar Documents

Publication Publication Date Title
DE3484997D1 (de) Zellstimulierendes mittel.
IL105017A0 (en) Pharmaceutical composition containing a defined lipid system
DK169683A (da) Mundplejemiddel
JPS54160353A (en) Novel phenoxyalkylcarboxylic derivative or its salt and sedative or antiiinflammatory agent containing them as active ingredient
NZ188721A (en) Imidazolidines and pharmaceutical compositions
IT8348746A0 (it) Derivati amminometil-benzenici arilsostituiti ad attivita' regolatrice del ritmo cardiaco e composizioni che li contengono
PH13921A (en) Pharmacologically active pyrimidine derivatives and compositions thereof
IT1205337B (it) Derivati amminometil-benzenici eteroaril-sostituiti ad attivita' regolatrice del ritmo cardiaco e composizioni farmaceutiche che li contengono
IE781032L (en) Pharmaceutical compositions
DE3068803D1 (en) The use of 2-phenyltetralin derivatives, or heterocyclic analogues, in medicine and pharmaceutical compositions containing them
ZA812088B (en) Derivative of saccharide and physiologically active agent containing the same
SE8504976L (sv) Ogondroppar innehallande bromocriptin
IL78061A (en) Pharmaceutical compositions based on simethicone and guar gum for protection of the oesogastroduodenal mucous membrane
ES458123A1 (es) Un procedimiento para la preparacion de nuevos derivados de adenina.
JPS55111494A (en) Monophosphonate compound* its manufacture and therapeutic composition containing same as active ingredient
JPS565465A (en) Benzimidazole derivative* its manufacture and medicinal composition of same as active component
NZ184766A (en) Alkylphenyl ethers and thioethers and pharmaceutical compositions
ES8303085A1 (es) Un procedimiento para la preparacion de una composicion antitranspirante a base de sales de aluminio y zirconio.
SE8300495D0 (sv) Improvements in or relating to nasal pharmaceutical compositions
ZA773979B (en) Pharmaceutically active benzamine compounds and compositions
IT1106299B (it) 5-imminodaunomicina e suoi derivati procedimento per prepararla nonch' composizioni farmaceutiche che la contengono
GB2021409A (en) Pharmaceutical composition
NZ191006A (en) Pyrimidine derivatives of isoureas and isothioureas pharmaceutical compositions
IT8222911A0 (it) Derivati della 1-metil-5-nitro-imidazolina e composizioni terapeutiche che li comprendono come principio attivo.
BE888525A (fr) Nucleoside de la classe des desazapurines, compositions en contenant et leur application en medecine,

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8300495-2

Format of ref document f/p: F

NUG Patent has lapsed